EMA Authorised: Teriparatide Sun (teriparatide) — Sun Pharmaceutical Industries Europe B.V.

View source ↗

Summary

The EMA authorised Teriparatide Sun for osteoporosis, including postmenopausal osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Teriparatide Sun (teriparatide)

Snippet

Status: Authorised. Therapeutic area: Osteoporosis;Osteoporosis, Postmenopausal. MAH: Sun Pharmaceutical Industries Europe B.V.. Decision date: 09/10/2025